Fuji Pharma Co Ltd
TSE:4554
Fuji Pharma Co Ltd
TSE:4554
Price:
1 552 JPY
0.58%
Market Closed
Updated:
Apr 29, 2024
Fuji Pharma Co Ltd
Cash from Operating Activities
|
Fuji Pharma Co Ltd
Cash from Operating Activities Peer Comparison
Comparables:
4502
4568
4578
4519
4503
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Fuji Pharma Co Ltd
TSE:4554
|
Cash from Operating Activities
¥1.9B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-6%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Cash from Operating Activities
¥731.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
17%
|
CAGR 10-Years
13%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Cash from Operating Activities
¥595.3B
|
CAGR 3-Years
47%
|
CAGR 5-Years
47%
|
CAGR 10-Years
25%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Cash from Operating Activities
¥283.2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
16%
|
CAGR 10-Years
4%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Cash from Operating Activities
¥409.9B
|
CAGR 3-Years
26%
|
CAGR 5-Years
28%
|
CAGR 10-Years
23%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Cash from Operating Activities
¥216.1B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
See Also
What is Fuji Pharma Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
1.9B
JPY
1.9B
JPY
Based on the financial report for Dec 31, 2023, Fuji Pharma Co Ltd's Cash from Operating Activities amounts to 1.9B JPY.
What is Fuji Pharma Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-6%
-6%
The average annual Cash from Operating Activities growth rates for Fuji Pharma Co Ltd have been -31% over the past three years , -13% over the past five years , and -6% over the past ten years .
You don't have any saved screeners yet
